![Marianne Brüggemann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marianne Brüggemann
Direttore Tecnico/Scientifico/R&S presso Open Monoclonal Technology, Inc.
Posizioni attive di Marianne Brüggemann
Società | Posizione | Inizio | Fine |
---|---|---|---|
Open Monoclonal Technology, Inc.
![]() Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | - |
Storia della carriera di Marianne Brüggemann
Precedenti posizioni note di Marianne Brüggemann
Società | Posizione | Inizio | Fine |
---|---|---|---|
The Babraham Institute
![]() The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Open Monoclonal Technology, Inc.
![]() Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Health Technology |
The Babraham Institute
![]() The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
- Borsa valori
- Insiders
- Marianne Brüggemann
- Esperienza